Treatment of menopausal symptoms in family medicine settings following the women's health initiative findings

Journal of the American Board of Family Medicine

Volumn 19, Issue 2, 2006, Pages 122-131

  Burg, Mary Ann ^a   Fraser, Kathryn ^b   Gui, Serena ^c   Grant, Kathryn ^a   Kosch, Shae Graham ^a   Nierenberg, Barry ^d   Oyama, Oliver ^e   Pomm, Heidi ^f   Sibille, Kimberly ^g   Spruill, Timothy ^c   Swartz, Virginia ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b HALIFAX MEDICAL CENTER   (United States)

^c FLORIDA HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e Morton Plant Mease/University of South Florida   (United States)

^f St Vincent's Medical Center Jacksonville   (United States)

^g Bayfront Med Center St Petersburg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY MEDICINE; FEMALE; HEALTH CARE; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; MALE; MENOPAUSAL SYNDROME; MENSTRUAL IRREGULARITY; QUESTIONNAIRE; RESIDENCY EDUCATION; UNITED STATES; VAGINAL DRYNESS; VASOMOTOR DISORDER;

AGED; CLIMACTERIC; COMPLEMENTARY THERAPIES; DRUG UTILIZATION; ESTROGEN REPLACEMENT THERAPY; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; FEMALE; FLORIDA; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; INTERNSHIP AND RESIDENCY; LIFE STYLE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; WOMEN'S HEALTH;

EID: 33745886847     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.19.2.122     Document Type: Article

References (22)

1. Cheung AM, Chaudry R, Kapral M, Jackvicius C, Robinson G. Perimenopausal and postmenopausal health. BMC Women's Health 2004;4(Suppl 1):S23.
2. Gracia CR, Freeman EW. Acute consequences of the menopausal transition: the rise of common menopausal symptoms. Endocrinol Metab Clin North Am 2004;33:675-89.
3. Dennerstein L, Duddley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-8.
4. Cutson TM, Meuleman E. Managing menopause. Am Fam Physician 2000;61:1391-400.
5. Gorsky RD, Koplan JP, Peterson HB, Thacker SB. Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Obstet Gynecol 1994;83:161-6.
6. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy. JAMA 2004;291:47-53.
7. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
8. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative Randomized Control Trial. JAMA 2002;288:321-33.
9. Mosca L, Collins P, Herrrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:499-503.
10. Humphrey LL, Chan BKS, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002;137:273-84.
11. Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA 2004;292:1983-8.
12. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701-12.
13. Barber CA, Margolis K, Luepker RV, Arnett DK. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002). J Women's Health 2004;13:975-85.
14. Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-32.
15. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184-8.
16. Kliger B. Black cohosh. Am Fam Physician 2003;68:114-6.
17. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-13.
18. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flashes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992;167:436-9.
19. Irvin JH, Domar AD, Clark C, Zuttermeister PC, Friedman R. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996;17:202-7.
20. Bastian LA, Breslau ES, Davis WW, Moser RP. Hormone therapy for menopausal symptoms: tracking the translation of the Women's Health Initiative findings. JCOM 2005;12:140-6.
21. NIH State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: management of menopause-related symptoms. Ann Intern Med 2005;142:1003-13.
22. U.S. Preventive Services Task Force. Chemoprevention for hormone replacement therapy. Release date: 2002. Available from: http://www.ahcpr.gov/ clinic/uspstf/uspspmho.htm